|
|
||||||||
From the Departments of Anesthesia and Critical Care (Drs. Jakubowski and Burstein), Beth Israel Deaconess Medical Center; Department of Neurobiology and the Program in Neuroscience (Dr. Burstein), Harvard Medical School, Boston, MA; and Department of Neurology (Drs. Silberstein and Ashkenazi), Thomas Jefferson University Hospital, Jefferson Headache Center, Philadelphia, PA.
Address correspondence and reprint requests to Dr. Rami Burstein, Department of Anesthesia and Critical Care, Harvard Institutes of Medicine, Room 830, 77 Avenue Louis Pasteur, Boston, MA 02115; e-mail: rburstei{at}caregroup.harvard.edu
Objective: The gradual development of cutaneous allodynia during the course of a migraine attack is commonly detected by quantitative sensory testing (QST) in migraineurs seeking secondary and tertiary medical help. In this study, the authors developed a questionnaire that tested the recollection of the patients on their skin sensitivity during past migraine attacks.
Methods: The authors devised a series of questions regarding skin sensitivity during migraine and posed them to 89 migraineurs when they were free of migraine (Visit 1). To validate their recollections, the authors determined the patients' pain thresholds to mechanical and thermal skin stimuli in the absence of migraine (Visit 1) and during an attack (Visit 2), using QST.
Results: Whereas 75.3% of the patients testified to at least one type of skin hypersensitivity during migraine, 24.7% were unaware of any abnormal skin sensitivity. The questionnaire correctly identified 84.8% of the 66 patients classified as allodynic by QST and mislabeled the remaining 15.2% as nonallodynic (false negatives). Among the 23 patients classified as nonallodynic by QST, 47.8% were mislabeled as allodynic using the questionnaire (false positives). Among the total number of 89 patients studied, the questionnaire produced 62.9% true positives and 13.5% true negatives (= 76.4% correct labeling) vs 12.4% false positives and 11.2% false negatives (= 23.6% mislabeling).
Conclusion: The reliability of the questionnaire as a diagnostic tool of allodynia varies with the proportion of allodynic patients in a given clinic. The major source of variability is the misconception of nonallodynic patients that their skin is hypersensitive during migraine.
Supported by a grant from GlaxoSmithKline, and by National Institutes of Health grants DE13347 (National Institutes of Dental and Craniofacial Research) and NS35611 (National Institutes of Neurological Disorder and Stroke) to R.B.
Disclosure: The following compensations from GlaxoSmithKline were in excess of $10,000: the grant for the study, honoraria to Rami Burstein, PhD, and Stephen Silberstein's, MD, equity in the company. Moshe Jakubowski, PhD, and Avi Ashkenazi, MD, report no conflicts of interest.
Received May 8, 2005. Accepted in final form July 25, 2005.
This article has been cited by other articles:
![]() |
M. E. Bigal, S. Ashina, R. Burstein, M. L. Reed, D. Buse, D. Serrano, R. B. Lipton, and On behalf of the AMPP Group Prevalence and characteristics of allodynia in headache sufferers: A population study Neurology, April 22, 2008; 70(17): 1525 - 1533. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |